SAN PEDRO, Calif.--(BUSINESS WIRE)--Celprogen Inc., a Global leader in the Stem Cell Research and Therapeutics industry for development of stem cell technologies in regenerative medicine, today announced that they have successfully validated shipment of embryonic and adult stem cells at room temperature within United States research facilities for in vivo applications. These Stems including progenitor cells were derived from the following species mouse, rat and human.
